US EditionSanofi All In on Digital Drugmaking
Digitization has allowed Sanofi to optimize manufacturing and automate document preparation. And now, the firm predicts that AI will soon help it reduce development and manufacturing timelines by 25%. The French drug maker set out to become a “digital healthcare company” in 2022, setting a goal of using digitization to drive innovation and efficiencies across R&D, manufacturing, and commercial operations by 2025. And results have been positive, …
1 Articles
1 Articles
Sanofi All In on Digital Drugmaking
Digitization has allowed Sanofi to optimize manufacturing and automate document preparation. And now, the firm predicts that AI will soon help it reduce development and manufacturing timelines by 25%. The French drug maker set out to become a “digital healthcare company” in 2022, setting a goal of using digitization to drive innovation and efficiencies across R&D, manufacturing, and commercial operations by 2025. And results have been positive, …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
